A phase 2 trial of CD24Fc for prevention of graft-versus-host disease.
Magenau J, Jaglowski S, Uberti J, Farag SS, Riwes MM, Pawarode A, Anand S, Ghosh M, Maciejewski J, Braun T, Devenport M, Lu S, Banerjee B, DaSilva C, Devine S, Zhang MJ, Burns LJ, Liu Y, Zheng P, Reddy P.
Magenau J, et al.
Blood. 2024 Jan 4;143(1):21-31. doi: 10.1182/blood.2023020250.
Blood. 2024.
PMID: 37647633
Clinical Trial.